Related references
Note: Only part of the references are listed.Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma
Qun Cai et al.
FRONTIERS IN ONCOLOGY (2022)
A Novel Immune-Related Prognostic Signature Predicting Survival in Patients with Pancreatic Adenocarcinoma
Xiao Zhang et al.
JOURNAL OF ONCOLOGY (2022)
Dilemma and Challenge of Immunotherapy for Pancreatic Cancer
Jia Wu et al.
DIGESTIVE DISEASES AND SCIENCES (2021)
Association Between TP53 Mutation and Prognosis in Wilms Tumor: A Meta-Analysis
Li Lizhi et al.
FETAL AND PEDIATRIC PATHOLOGY (2021)
S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine
Ting Li et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective
Sijia Gu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways
Dan Fang et al.
CELL BIOLOGY AND TOXICOLOGY (2021)
S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway
Shiyu Ou et al.
MOLECULAR MEDICINE REPORTS (2021)
Individualized prognostic signature for pancreatic carcinoma validated by integrating immune-related gene pairs (IRGPs)
Yecheng Li et al.
BIOENGINEERED (2021)
Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma
Bo Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
Weijia Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles
Qianwen Yu et al.
ACTA BIOMATERIALIA (2021)
Successful Immunotherapy for Pancreatic Cancer in a Patient With TSC2 and SMAD4 Mutations: A Case Report
Yanghui Ye et al.
FRONTIERS IN IMMUNOLOGY (2021)
TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer
Ziwen Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Expressional and Prognostic Value of S100A16 in Pancreatic Cancer Via Integrated Bioinformatics Analyses
Gangping Tu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Pancreatic Cancer: A Review
Wungki Park et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Cell death in pancreatic cancer: from pathogenesis to therapy
Xin Chen et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer
Qiyao Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer
Dujuan Cao et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2021)
Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features
Yalan Lei et al.
BIOENGINEERED (2021)
Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer
Xiaoxiao Liu et al.
ADVANCED BIOLOGY (2021)
CD40 Agonist Antibodies in Cancer Immunotherapy
Robert H. Vonderheide
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Nanotechnology platforms for cancer immunotherapy
Zhaogang Yang et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
FAM83H overexpression predicts worse prognosis and correlates with less CD8+ T cells infiltration and Ras-PI3K-Akt-mTOR signaling pathway in pancreatic cancer
H. Zhuang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients
He Cheng et al.
CANCER MEDICINE (2020)
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Keisuke Yamamoto et al.
NATURE (2020)
Role of S100 proteins in health and disease
Laura L. Gonzalez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients
Fanqin Bu et al.
IMMUNITY INFLAMMATION AND DISEASE (2020)
Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain
Zhi-Hua Xu et al.
FASEB JOURNAL (2019)
Characteristics and Outcomes of Pancreatic Cancer by Histological Subtypes
Guopei Luo et al.
PANCREAS (2019)
Emerging immune gene signatures as prognostic or predictive biomarkers in breast cancer
Mi Jeong Kwon
ARCHIVES OF PHARMACAL RESEARCH (2019)
Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
M. Oliva et al.
ANNALS OF ONCOLOGY (2019)
Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity
Chien-Chun Steven Pai et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Harnessing the Microbiome for Pancreatic Cancer Immunotherapy
Gerardo A. Vitiello et al.
TRENDS IN CANCER (2019)
S100A16 is a prognostic marker for colorectal cancer
Xu Sun et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes
Bo-Wei Han et al.
BMC GENOMICS (2018)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Current standards and new innovative approaches for treatment of pancreatic cancer
Thierry Conroy et al.
EUROPEAN JOURNAL OF CANCER (2016)
Immunotherapy for pancreatic cancer
Elias Kotteas et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review
Yandiswa Yolanda Yako et al.
PLOS ONE (2016)
PD-L1 Testing in Cancer Challenges in Companion Diagnostic Development
Aaron R. Hansen et al.
JAMA ONCOLOGY (2016)
Immune Therapy in GI Malignancies: A Review
Judy Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo
Linda C. Sandin et al.
ONCOIMMUNOLOGY (2014)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
Chao-Ying Liu et al.
LABORATORY INVESTIGATION (2013)
Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection
Chao Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: A pilot study of safety, feasibility, and immune activation
Dan Laheru et al.
CLINICAL CANCER RESEARCH (2008)